Inhibition of tumor growth and angiogenesis of tamoxifen‑resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor
Ji Eun Kim(Cancer Society of New Zealand), Keon Wook Kang(Seoul National University)
Cited by 61
Related Papers
Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells
|Endocrine Related Cancer|2007|87
Secreted protein acidic and rich in cysteine mediates active targeting of human serum albumin in U87MG xenograft mouse models
|Theranostics|2019|82
Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells
|Oncotarget|2015|33
Imaging of Indocyanine Green-Human Serum Albumin (ICG-HSA) Complex in Secreted Protein Acidic and Rich in Cysteine (SPARC)-Expressing Glioblastoma
|International Journal of Molecular Sciences|2023|28